📰 Review Machine News
Review Machine News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Review Machine. Real-time updates on events, politics, business and more.
July 20, 2023
An AI tool can rapidly decode a brain tumor’s DNA to determine its molecular identity during surgery — critical information that under the current approach
July 20, 2023
Artificial intelligence (AI) technology is accelerating the future of brain tumor treatment with the development of a tool that can swiftly decode a tumor's DNA to determine its molecular identity — all during surgery. This process, which presently can take several days to a few weeks, is vital for informing critical surgical decisions such as the amount of brain tissue to remove and the necessity of immediate tumor-destroying drugs. Don’t Miss: Until 2016 it was illegal for r...
July 14, 2023
THURSDAY, July 13, 2023 (HealthDay News) -- An artificial intelligence system can identify cancer cells and predict genetic mutation status of gliomas using intraoperative cryosection samples, according to a study published online July 7 in Med. Noting that intraoperative cryosection evaluation remains the gold standard for guideline surgical treatments for gliomas, but that the tissue-freezing
July 11, 2023
An artificial-intelligence tool has shown promise at helping doctors fight aggressive brain tumors by identifying characteristics that help guide surgery.
July 10, 2023
An artificial-intelligence tool has shown promise at helping doctors fight aggressive brain tumours by identifying characteristics that help guide surgery.
July 10, 2023
While glioma varies in severity, an aggressive form called glioblastoma can lead to death in less than six months if untreated. Only 17% of people with glioblastoma survive their second year after being diagnosed, according to the American Association of Neurological Surgeons.
July 8, 2023
New AI tool enables in-surgery genomic profiling of gliomas, the most aggressive and most common brain tumors. This information offers critical clues about how aggressive a cancer is, its future behavior, and its likely response to treatment. The tool can provide real-time guidance to surgeons on the optimal surgical approach for removal of cancerous tissue.
July 8, 2023
The tool — called the Cryosection Histopathology Assessment and Review Machine, or CHARM — studies images to quickly pick out the genetic profile of a kind of tumor called glioma, a process that currently takes days or weeks.